Tessa Therapeutics Names Biopharma Veteran Jeffrey H. Buchalte...
SINGAPORE, March 1, 2019 /PRNewswire-AsiaNet/ -- Tessa Therapeutics, a clinical-stage immunotherapy company focused on autologous and off-the-shelf, allogeneic therapies targeting solid tumors, today announced the appointment of Mr. Jeffrey H. Buchalter as an independent director.Mr. Buchalt...
Authors: LATEST ASIANET NEWS RELEASES